The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pre-planned safety analysis of NORDIC 9: A randomized trial comparing full dose monotherapy (S-1) with reduced dose combination therapy (S-1/oxaliplatin) in older chemo-naive patients with metastatic colorectal cancer (mCRC).
 
Stine Brændegaard Winther
No Relationships to Disclose
 
Pia J. Osterlund
No Relationships to Disclose
 
Ake Berglund
No Relationships to Disclose
 
Bengt Glimelius
No Relationships to Disclose
 
Camilla Qvortrup
No Relationships to Disclose
 
Halfdan Sorbye
No Relationships to Disclose
 
Per Pfeiffer
Research Funding - Taiho Pharmaceutical (Inst)